AMP
Inex Innovate to Launch PCR-Based Endometrial Cancer Detection Test
The Singapore-based company plans to launch the epiHera test in August, following interim results from a clinical study with researchers at the Chinese University of Hong Kong.
AMP, NSGC Issue New Recommendations for Confirming Germline Variants From NGS Tests
The guidelines are the product of a working group convened by the Association for Molecular Pathology that assessed the literature, surveys, and public comment.
Results from a homologous recombination deficiency assay concordance study led by Friends of Cancer Research were presented at the AMP annual meeting.
At the AMP annual meeting last week, two lab directors shared their experiences and discussed the assay's pros and cons in a company-sponsored workshop.
Thermo Fisher Introduces Homologous Recombination Deficiency Score for Cancer Profiling Assay
Premium
The firm is also bringing its comprehensive genomic profiling assay for cancer to the Ion Torrent Genexus sequencing platform in the first half of 2023.